The focus of Ecker + Ecker is on health care questions of the German market.

In this area, Ecker + Ecker provides comprehensive support for manufacturers of pharmaceuticals, medical devices and diagnostics.

Market Access

  • What are the market access hurdles for my product?
  • How does benefit assessment according to AMNOG impact market access in Germany?
  • Who are key stakeholders on national and regional level? How do you approach them? How do you communicate?
  • What are the interfaces with traditional sales activities?
  • How can success in market access be measured?

Benefit Assessment (AMNOG)

  • What are the components of a successful strategy?
  • What do we need apart from a good dossier?
  • How can you negotiate successfully?

Benefit Assessment of high-risk Medical Devices

  • Is my product subject to this new assessment?
  • What are the risks involved?
  • How can you prepare best?

Pricing and Reimbursement

  • What are typical rebates under AMNOG?
  • How does price negotation in Germany influence international launch sequence?
  • Which reimbursement hurdles do exist apart from AMNOG?

Reference Pricing for Pharmaceuticals

  • What reference price do we have to expect?
  • How to influence reference pricing and reference price level?
  • When will the reference price change?
  • Is a hearing procedure worthwhile?
  • How should the statement be presented?

Indirect Comparisons and Meta-Analyses

  • How can indirect comparisons enhance my product's evidence?
  • How should an indirect comparison for the German benefit assessment be designed?

Clinical Trial Evaluation for the German Benefit Assessment

  • How can you optimally edit the trial data?
  • Which additional analyses are necessary and helpful?

Bids and Tendering

  • Which are the current tenders?
  • How can you find the best bid?
  • Does this contract pay?
created by - sehstrand -